☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
P-IIa
Hepion Reports Results of CRV431 in P-IIa AMBITION Trial for the Treatment of NASH
July 14, 2021
Urovant's Vibegron Fails to Meet its Primary Endpoint in P-IIa Study for IBS Pain
November 26, 2020
Bicycle Reports First Patient Dosing in P-IIa Study of BT1718 for MT1-MMP-Positive Squamous NSCLC
September 3, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.